U.S. Markets closed

Attis Industries Presents Second Video Providing an Overview of its Biomass Process Technology and R&D Facility Capabilities

MILTON, GA , Nov. 19, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Attis Industries Inc. (ATIS) (the “Company” or “Attis”), a diversified innovation and technology holding company emphasizing renewable fuels, bio-based plastics, healthcare, and plans to build a communications infrastructure business, today released the second video in a series, designed to offer investors, future clients and interested parties additional information on the technologies and bio-based products offered under the Company’s Innovations division.  This video focuses on Attis’ biomass process technology, the unique products it can deliver and the capabilities of our existing R&D facility in Wausau, WI.

Link to video: https://bit.ly/2S096wi

Attis’ R&D facility is an integral part of the Company’s operations and plays a critical role in biomass characterization and lignin and cellulose testing for end products.  The existing process in Wausau serves as a pilot scale demonstration for what will be our first commercial scale operation, allowing Attis to further refine process efficiencies, without the risk associated with process changes at full commercial-scale. 

Jeff Cosman, Chief Executive Officer of Attis Industries, commented, “The team at our R&D facility in Wausau has over 30 years of combined biomass processing and laboratory expertise.  Their institutional knowledge and facility operations bring tremendous value to Attis, allowing us to demonstrate on a pilot scale our biomass processing technology, as well as, invaluable testing on our unique lignin and cellulose for end product uses.  We are excited to showcase our R&D facilities capabilities and give everyone a better understanding of how this revolutionary technology can bring transformative global change to multiple industries including biofuels, plastics, and other bio-based products.”

In the coming months, additional videos will be posted on the Attis Industries website as part of our commitment to creating shareholder value and operational transparency. Attis will continue to focus on key segments of our unique and diversified business as well as market potential throughout our companies divisions.

About Attis Industries Inc.
Attis Industries Inc. (ATIS) is a holding company focused on developing and building businesses that play important roles in the new economy, which include renewable fuels, bio-based plastics, healthcare and communications infrastructure. We strive to encourage our employees to be entrepreneurs focused on innovation and technology. We will remain dynamic, persistent and motivated to our mission of winning. The growth of our company will rely on our integrity and our vision for the future. Attis Industries will continue to fulfill essential needs in healthcare, energy independence and digital communications. Today, each of these sectors provide high growth opportunities that collectively account for more than a third of America’s GDP. For more information, visit: www.attisind.com.

Forward-Looking Statements
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. You can identify forward-looking statements by words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “should,” “would” or similar words. You should consider these statements carefully because they discuss our plans, targets, strategies, prospects and expectations concerning our business, operating results, financial condition and other similar matters. These statements are subject to certain risks, uncertainties, and assumptions, including, but not limited to, risks and uncertainties relating to the Company's ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company's products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, clinical studies and future product commercialization; and, the Company's business, research, product development, regulatory approval, marketing and distribution plans and strategies; the ability of the Company to continue to meet the listing requirements of NASDAQ; the ability of the Company to execute on a business plan that permits the technologies and innovations businesses to provide sufficient growth, revenue, liquidity and cash flows for sustaining the Company’s go-forward business, and the risks identified and discussed under the caption “Risk Factors” in the Attis Annual Report on Form 10-K for the fiscal year ended December 31, 2017, filed with the Securities and Exchange Commission (the “SEC”) on April 16, 2018 and the other documents Attis files with the SEC from time to time. There will be events in the future, however, that Attis is not able to predict accurately or control. Attis’s actual results may differ materially from the expectations that Attis describes in its forward-looking statements. Factors or events that could cause Attis’s actual results to materially differ may emerge from time to time, and it is not possible for Attis to accurately predict all of them. Any forward-looking statement made by Attis in this press release speaks only as of the date on which Attis makes it. Attis undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.


Media and Investors Contact:
Hayden IR
(917) 658-7878
hart@haydenir.com